Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same author

The Effect of Thymectomy on the Incidence of Extrathymic Cancers and Autoimmune Diseases in Patients With Non-Thymomatous Myasthenia Gravis.

Muscle & nerve·2026
Same author

Open-label study of efgartigimod in seronegative myasthenia gravis.

Therapeutic advances in neurological disorders·2025
Same author

AI-Based EMG Reporting: A Randomized Controlled Trial.

Journal of neurology·2025
Same author

Malignancy in neuromuscular patients on chronic IVIG.

Frontiers in neurology·2025
Same author

Agent-guided AI-powered interpretation and reporting of nerve conduction studies and EMG (INSPIRE).

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2025

Related Experiment Video

Updated: May 5, 2026

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
10:09

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

52.1K

Cortical Intra-Layer Hypersynchronization in Levodopa-Induced Dyskinesia Mouse Model.

Mohamed Khateb1,2, Fadi Aeed1, Shay Achvat3

  • 1Department of Neurology, Rambam Medical Center, Haifa, Israel.

Brain and Behavior
|October 21, 2025
PubMed
Summary

Levodopa-induced dyskinesia (LID) in Parkinson's disease is linked to abnormal brain activity. New research reveals hypersynchronization within the motor cortex during LID, offering insights into this movement disorder.

Keywords:
levodopa‐induced dyskinesia | motor cortex | Parkinson's disease | synchronization

More Related Videos

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.3K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.4K

Related Experiment Videos

Last Updated: May 5, 2026

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
10:09

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

52.1K
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.3K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.4K

Area of Science:

  • Neuroscience
  • Motor Control
  • Parkinson's Disease Research

Background:

  • Levodopa-induced dyskinesia (LID) is a significant complication for Parkinson's disease (PD) patients.
  • LID may stem from altered activity in the motor cortex (M1) and basal ganglia (BG).
  • Previous electrophysiological studies were limited by technological constraints in recording from multiple neurons across brain regions.

Purpose of the Study:

  • To investigate the neural network changes associated with LID using advanced electrophysiological techniques.
  • To compare neuronal activity and functional connectivity in M1 and the striatum across different PD and LID states.

Main Methods:

  • Utilized Neuropixels technology for high-density extracellular recordings in awake mice.
  • Recorded neural activity simultaneously from the primary motor cortex (M1) and motor striatum.
  • Compared neuronal firing rates and synchrony in wild-type, parkinsonian, and LID models.

Main Results:

  • M1 firing rates decreased in Parkinson's disease (PD) and increased in LID.
  • A novel finding of intra-layer hypersynchronization among M1 neurons (Layers 2, 3, 5) was observed in LID.
  • Increased inter-layer synchrony between M1 Layer 5 and the striatum was evident in LID, but not in control mice.

Conclusions:

  • High-density recordings reveal LID is associated with intra-layer hypersynchronization within the motor cortex.
  • This hypersynchronization may represent an intrinsic network alteration in the cortico-basal ganglia loop.
  • Findings provide new insights into the neural mechanisms underlying levodopa-induced dyskinesia.